Joyce S. Hui-Yuen

Joyce S. Hui-Yuen

Pediatric Rheumatology

410 Lakeville Road
Suite 300
Lake Success, NY 11042

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Type I Interferon-Driven Monocyte Dysregulation and MAS-associated CD8 + T cells During Macrophage Activation Syndrome.

Type I Interferon-Driven Monocyte Dysregulation and MAS-associated CD8 + T cells During Macrophage Activation Syndrome.

Journal: bioRxiv : the preprint server for biology

Published: June 05, 2026

Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis.

Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis.

Journal: ACR open rheumatology

Published: May 15, 2025

Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis.

Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis.

Journal: Clinical and experimental rheumatology

Published: October 31, 2024

Discordant Perception of Disease Activity Between Providers and Adolescents with Systemic Lupus Erythematosus: A Cohort Study.

Discordant Perception of Disease Activity Between Providers and Adolescents with Systemic Lupus Erythematosus: A Cohort Study.

Journal: The Journal of pediatrics

Published: April 16, 2024

B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children.

B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children.

Journal: Lupus science & medicine

Published: February 23, 2023

The safety of COVID-19 vaccination in immunocompromised children and young adults with immune-mediated inflammatory disease.

The safety of COVID-19 vaccination in immunocompromised children and young adults with immune-mediated inflammatory disease.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: November 11, 2022

Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis.

Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 03, 2022

Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease.

Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease.

Journal: Rheumatology (Oxford, England)

Published: June 09, 2021

Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Clinicians From 2010 to 2018.

Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Clinicians From 2010 to 2018.

Journal: The Journal of rheumatology

Published: January 08, 2021

Emerging B-Cell Therapies in Systemic Lupus Erythematosus.

Emerging B-Cell Therapies in Systemic Lupus Erythematosus.

Journal: Therapeutics and clinical risk management

Published: October 09, 2020

Performance and psychometric properties of lupus impact tracker in assessing patient-reported outcomes in pediatric lupus: Report from a pilot study.

Performance and psychometric properties of lupus impact tracker in assessing patient-reported outcomes in pediatric lupus: Report from a pilot study.

Journal: Lupus

Published: August 26, 2020

Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab.

Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab.

Journal: Drug design, development and therapy

Published: March 07, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026